| Metric | Q2'26 | Q3'26 | Change |
|---|---|---|---|
| Revenue | $3.0B, +37.7% YoY | $3.66B, +58.5% YoY | +2,080bps YoY growth acceleration |
| Diluted EPS | $1.02 | $1.20 | +17.6% QoQ, beat guide of $1.06-$1.08 |
| Net income margin | 42.9% of revenue | 41.9% of revenue | -100bps despite dollar growth |
| Operating margin | 49.9% | 49.1% | -80bps on R&D spend ramp |
| Gross margin | 63.4% | 64.0% | +60bps sequentially |
| R&D spend | $278.1M, 9.2% of rev | $408.5M, 11.2% of rev | +47% QoQ, above stated 9-11% framework midpoint |
| Cash flow from ops (CFFO) | $1.1B | $1.2B | +9% but gap to net income widened |
| Inventory | $2.5B | $3.2B | +28% QoQ, outpacing 22% revenue growth |
| Purchase commitments | $9.7B | $11.4B | +17.5% QoQ, guided to rise further in Q4 |
| Total deferred revenue | $6.9B, +$600M seq | $6.8B, -$86M seq | Reversed from growth to decline |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.